- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 19-08-2025: Press Release
19-08-2025 | 11:17 am
19-08-2025 | 11:17 am
Alembic Pharma secured USFDA final approval for Macitentan Tablets, 10 mg, for pulmonary arterial hypertension. This drug targets an estimated market size of ~₹9,794 Cr, presenting a notable growth opportunity.
No comments yet. Be the first to comment!